Skip to content

Effect of auricular point sticking on pregnancy rate of patients with polycystic ovary syndrome

Effect of auricular point sticking on pregnancy rate of patients with polycystic ovary syndrome

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014580
Enrollment
Unknown
Registered
2018-01-22
Start date
2018-03-15
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

Group 1:Auricular point sticking
Group 2:Lifestyle adjustment

Sponsors

Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: The Rotterdam PCOS diagnostic criteria for the following 2 of 3: 1. Oligo-ovulation or anovulation 2. The Hyperandrogenism or the clinical manifestations hyperandrogenism (such as hirsutism, acne, etc.) 3. Ultrasound examination in the menstrual cycle or bleeding 3~5d after progesterone withdrawal, bilateral ovarian has more than 12 small follicles with 2~9mm diameter, meaning Polycystic ovary changes and (or) enlarged ovary (Ovarian >10ml per side, ovarian volume =0.5 * length(cm) * width (cm) * thick(cm))

Exclusion criteria

Exclusion criteria: 1. Other causes of hyperandrogenism, such as androgen-producing tumors; 2. Hyperprolactinemia, adrenal disease or thyroid dysfunction; 3. Nearly three months had hormone therapy; 4. Serious cardiovascular disease: heart,lung, liver, kidney and hematopoietic system ,and other serious primary diseases and mental illness; 5. Check for genital organic disease (uterine fibroids, adenomyosis, pituitary tumors, tubal obstruction, etc.), endometriosis; 6. Diabetes mellitus, severe infections and trauma, surgical major surgery, clinically hypotensive and hypoxic; 7. Habitual abortion; 8. Pregnancy, lactation; 9. Do not stay on the king of allergies; 10. Has been serving ovulation drugs, refused to randomize, can not cooperate with the treatment, and can not follow the observer.

Design outcomes

Primary

MeasureTime frame
The pregnancy rate;

Countries

China

Contacts

Public ContactLinlin Zhou

Guangzhou Medical University

15622175329@163.com+86 15622175329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026